首页 | 本学科首页   官方微博 | 高级检索  
检索        

经静脉移植骨髓间质干细胞治疗脑梗死
引用本文:张志坚,王伟,陈施艳,吴秀丽,苏津自,刘春风.经静脉移植骨髓间质干细胞治疗脑梗死[J].福建医科大学学报,2007,41(2):114-118.
作者姓名:张志坚  王伟  陈施艳  吴秀丽  苏津自  刘春风
作者单位:1. 福建医科大学,附属第一医院神经内科,福建省神经病学研究所,福建医科大学,神经生物学中心,福州 350005
2. 福建医科大学,附属第一医院心内科,福建省高血压研究所,福州 350005
3. 苏州大学,附属第二医院神经内科,苏州 215006
基金项目:教育部科学技术研究重点项目 , 福建省自然科学基金 , 福建医科大学校科研和教改项目
摘    要:目的 观察经静脉移植骨髓间质干细胞(MSC)治疗脑梗死时神经功能缺损的恢复情况,以及MSC在脑梗死灶的分布、迁移与分化情况.方法 经尾静脉将标记的大鼠骨髓间质干细胞(rMSC)或磷酸缓冲液(PBS)植入脑梗死鼠体内,于不同时程对动物神经功能状况进行评分.应用荧光标记及免疫组织化学方法检测移植细胞在脑内存活、迁移及分化情况,细胞化学染色观察rMSC体外分化情况.结果 与PBS组相比,rMSC组大鼠神经功能改善明显(P<0.001),在显微镜下可见脑移植细胞在梗死区及其周边区聚集并存活,有部分植入细胞分化表达神经细胞表面标志物,而在体外同时程培养的rMSC未见类似分化表达.结论 rMSC经静脉移植后能够在宿主脑内存活、迁移并分化表达神经细胞表型,有促进脑梗死后神经功能恢复的作用.经静脉路移植可以避免脑组织损伤,同时植入的rMSC能更均匀分布并聚集在脑梗死灶.

关 键 词:间质干细胞移植  脑梗死  疾病模型  动物
文章编号:1672-4194(2007)02-0114-05
修稿时间:2006-11-22

Effect of Intravenous Administration of Rat Mesenchymal Stem Cells after Cerebral Ischemia in Rats
Zhang Zhijian,Wang Wei,Chen Shiyan,Wu Xiuli,Su Jinzi,Liu Chunfeng.Effect of Intravenous Administration of Rat Mesenchymal Stem Cells after Cerebral Ischemia in Rats[J].Journal of Fujian Medical University,2007,41(2):114-118.
Authors:Zhang Zhijian  Wang Wei  Chen Shiyan  Wu Xiuli  Su Jinzi  Liu Chunfeng
Institution:1. Department of Neurology, The Affiliated First Hospital, Fujian Medical University, Fuzhou 350005, China; 2. Department of Cardiology, The Affiliated First Hospital, Fujian Medical University, Fuzhou 350005, China ;3.Dopartment of Neurology, The Affiliated Second Hospital, Suzhou University, Suzhou 215006, China
Abstract:Objective To observe the therapeutic effects of intravenous administration of rat mesenchymal stem cells(rMSC) after cerebral ischemia in adult rats, which include the improvement of neurological function, the migration of rMSC to infarct focus, and the differentiation of rMSC. Methods Adult male SD rats were subjected to transient(2 hours) middle cerebral artery occlusion(MCAO). rMSC or phosphate buffered saline(PBS) was injected into tail vein at 24 hour after MCAO. Functional outcome measurements using the modified neurological severity scores(mNSS) were performed at 24 hour post-MCAO, 1 week and 2 weeks post-transplantation respectively. Immunohistochemical staining and immunocytochemistry were used synchronously to identify rMSC and their differentiation markers in the brain sections and the cultured rMSC in vitro. Results There was significant neurological function improvement in rats treated with rMSC groups compared with that of PBS groups(P<0.001). After transplantation, rMSC were survived and localized around the ischemic core and its boundary zone, and a few rMSC expressed Nestin, NF-200 and GFAP, but there were no such expression in rMSC cultured in vitro. Conclusion Intravenous administration of rMSC can promote the neurological functional improvement in rat stroke model. rMSC can survive and localize in the ischemic area of the brain, and a few cells express the phenotypic protein marker of neural cells. The benefit of intravenous administration of rMSC show no brain injury and the better distribution of grafted cells.
Keywords:mesenchymal stem cells transplantation  brain infarction  disease model  animal
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《福建医科大学学报》浏览原始摘要信息
点击此处可从《福建医科大学学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号